There is scope for improving the services offered to patients with malignant glioma. Clinical audit has highlighted several important issues including some variation in the management of patients aged over 60,1 delays in beginning treatment, and problems with communication between different departments involved in patient care.2 A multidisciplinary Working Group, funded by the NHS Executive, recently developed evidence based guidelines for the management of these patients by surgery, radiotherapy, and chemotherapy. The group also considered the views of patients and their relatives about follow up and psychosocial aspects of care.3

We have derived a package of audit measures from these guidelines that allow treatment centres to assess the care that they provide.4 …